The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Open accessAbstract
By triggering immunogenic cell death, some anticancer compounds, including anthracyclines and oxaliplatin, elicit tumor-specific, interferon-γ–producing CD8+ αβ T lymphocytes (Tc1 CTLs) that are pivotal for an optimal therapeutic outcome. Here, we demonstrate that chemotherapy induces a rapid and prominent invasion of interleukin (IL)-17–producing γδ (Vγ4+ and Vγ6+) T lymphocytes (γδ T17 cells) that precedes the accumulation of Tc1 CTLs within the tumor bed. In T cell receptor δ−/− or Vγ4/6−/− mice, the therapeutic efficacy of chemotherapy was compromised, no IL-17 was produced by tumor-infiltrating T cells, and Tc1 CTLs failed to invade the tumor after treatment. Although γδ T17 cells could produce both IL-17A and IL-22, the absence of a functional IL-17A–IL-17R pathway significantly reduced tumor-specific T cell responses elicited by tumor cell death, and the efficacy of chemotherapy in four independent transplantable tumor models. Adoptive transfer of γδ T cells restored the efficacy of chemotherapy in IL-17A−/− hosts. The anticancer effect of infused γδ T cells was lost when they lacked either IL-1R1 or IL-17A. Conventional helper CD4+ αβ T cells failed to produce IL-17 after chemotherapy. We conclude that γδ T17 cells play a decisive role in chemotherapy-induced anticancer immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216 · cited 2×
“Thus, oxaliplatin (OX) and anthracyclines induce immunogenic cell death, whereas other chemotherapeutic agents such as cisplatin and alkylating agents tend to induce nonimmunogenic cell death (Casares et al., 2005; Obeid et al., 2007).”
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Self-citationGhiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898 · cited 8×
“…ATP released from dying tumor cells could trigger the purinergic P2RX7 receptor on host DC, stimulating the release of IL-1, which in turn facilitates the priming of CD8+ tumor-specific T cells for IFN- production that is indispensable for the success of chemotherapy (Ghiringhelli et al., 2009).”
InfluentialSelf-citationSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512 · cited 3×
“Thus, oxaliplatin (OX) and anthracyclines induce immunogenic cell death, whereas other chemotherapeutic agents such as cisplatin and alkylating agents tend to induce nonimmunogenic cell death (Casares et al., 2005; Obeid et al., 2007).”
Self-citationReboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“Expression of CCR6 is a phenotypic and functional hallmark of Th17 cells (Reboldi et al., 2009) during some inflammatory processes.”
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A., McAllister, F., Edeal, J., Gaus, K., et al. (2008) · Nature Medicine · doi:10.1038/nm1710 · Cited by 1,171
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A., Chapman, D. C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.1 · Cited by 848
Self-citationTumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Martin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Lockhart, E., Green, A. M., & Flynn, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4662 · Cited by 767
Ribot, J. C., deBarros, A., Pang, D. J., Neves, J. F., Peperzak, V., Roberts, S. J., Girardi, M., Borst, J., Hayday, A. C., Pennington, D. J., et al. (2009) · Nature Immunology · doi:10.1038/ni.1717 · Cited by 628 · cited 2×
“CD27+ thymocytes expressed LTR and genes associated with a Th1 phenotype, in contrast to CD27 thymocytes which give rise to IL-17–producing cells (Ribot et al., 2009).”
Lafaille, J. J., DeCloux, A., Bonneville, M., Takagaki, Y., & Tonegawa, S. (1989) · Cell · doi:10.1016/0092-8674(89)90609-0 · Cited by 565
Decoding Cell Death Signals in Inflammation and Immunity
Zitvogel, L., Kepp, O., & Kroemer, G. (2010) · Cell · doi:10.1016/j.cell.2010.02.015 · Cited by 558 · cited 1×
“The combined action of “find-me” and “eat-me” signals, together with the release of hidden molecules that are usually secluded within live cells may influence the switch between silent corpse removal and inflammatory reactions that stimulate the cellular immune response (Zitvogel et al., 2010).”
Self-citationγδ T cells for immune therapy of patients with lymphoid malignancies
Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T., & Tony, H.-P. (2003) · Blood · doi:10.1182/blood-2002-12-3665 · Cited by 550
Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
Self-citationvan Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W., Muller, F. J., Hommes, D. W., Zaat, S. A. J., Kapsenberg, M. L., & de Jong, E. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.013 · Cited by 518
Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0199 · Cited by 497
γδ T Cells and the Lymphoid Stress-Surveillance Response
Hayday, A. C. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.006 · Cited by 495
Li, L., Huang, L., Vergis, A. L., Ye, H., Bajwa, A., Narayan, V., Strieter, R. M., Rosin, D. L., & Okusa, M. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38702 · Cited by 487
Shibata, K., Yamada, H., Hara, H., Kishihara, K., & Yoshikai, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4466 · Cited by 483
Jensen, K. D. C., Su, X., Shin, S., Li, L., Youssef, S., Yamasaki, S., Steinman, L., Saito, T., Locksley, R. M., Davis, M. M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.022 · Cited by 480
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Kortylewski, M., Xin, H., Kujawski, M., Lee, H., Liu, Y., Harris, T., Drake, C., Pardoll, D., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.018 · Cited by 474
Nowak, A. K., Lake, R. A., Marzo, A. L., Scott, B., Heath, W. R., Collins, E. J., Frelinger, J. A., & Robinson, B. W. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4905 · Cited by 463
Diversity of murine gamma genes and expression in fetal and adult T lymphocytes
Heilig, J. S., & Tonegawa, S. (1986) · Nature · doi:10.1038/322836a0 · Cited by 448
The aryl hydrocarbon receptor in immunity
Esser, C., Rannug, A., & Stockinger, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.005 · Cited by 447
Peng, G., Wang, H. Y., Peng, W., Kiniwa, Y., Seo, K. H., & Wang, R.-F. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.020 · Cited by 408
Rachitskaya, A. V., Hansen, A. M., Horai, R., Li, Z., Villasmil, R., Luger, D., Nussenblatt, R. B., & Caspi, R. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5167 · Cited by 399
Induction, function and regulation of IL‐17‐producing T cells
Mills, K. H. G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838535 · Cited by 385
Hamada, S., Umemura, M., Shiono, T., Tanaka, K., Yahagi, A., Begum, M. D., Oshiro, K., Okamoto, Y., Watanabe, H., Kawakami, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3456 · Cited by 353
Self-citationThe co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344
Self-citationImplication of γδ T cells in the human immune response to cytomegalovirus
Déchanet, J., Merville, P., Lim, A., Retière, C., Pitard, V., Lafarge, X., Michelson, S., Méric, C., Hallet, M.-M., Kourilsky, P., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5409 · Cited by 338
Pichavant, M., Goya, S., Meyer, E. H., Johnston, R. A., Kim, H. Y., Matangkasombut, P., Zhu, M., Iwakura, Y., Savage, P. B., DeKruyff, R. H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071507 · Cited by 311
Godder, K. T., Henslee-Downey, P. J., Mehta, J., Park, B. S., Chiang, K.-Y., Abhyankar, S., & Lamb, L. S. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705650 · Cited by 306
Kim, S.-H., Henry, E. C., Kim, D.-K., Kim, Y.-H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J.-K., Gasiewicz, T. A., Ryu, S. H., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021832 · Cited by 286
Perspectives of γδ T Cells in Tumor Immunology
Kabelitz, D., Wesch, D., & He, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3069 · Cited by 251
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2002) · PubMed · Cited by 238
Type 17 CD8+ T cells display enhanced antitumor immunity
Hinrichs, C. S., Kaiser, A., Paulos, C. M., Cassard, L., Sanchez-Perez, L., Heemskerk, B., Wrzesinski, C., Borman, Z. A., Muranski, P., & Restifo, N. P. (2009) · Blood · doi:10.1182/blood-2009-02-203935 · Cited by 225
Doisne, J.-M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J.-B., Eberl, G., & Benlagha, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901059 · Cited by 168
Self-citationvan Burik, J. H., Carter, S. L., Freifeld, A. G., High, K. P., Godder, K. T., Papanicolaou, G. A., Mendizabal, A. M., Wagner, J. E., Yanovich, S., & Kernan, N. A. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.08.049 · Cited by 164
O'Brien, R. L., Roark, C. L., & Born, W. K. (2009) · European Journal of Immunology · doi:10.1002/eji.200839120 · Cited by 161
Do, J., Fink, P. J., Li, L., Spolski, R. J., Robinson, J., Leonard, W. J., Letterio, J. J., & Min, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903539 · Cited by 149
Up for Mischief? IL-17/Th17 in the tumour microenvironment
Maniati, E., Soper, R., & Hagemann, T. (2010) · Oncogene · doi:10.1038/onc.2010.367 · Cited by 131
Antigen recognition by CD1d-restricted NKT T cell receptors
Godfrey, D. I., Pellicci, D. G., Patel, O., Kjer‐Nielsen, L., McCluskey, J., & Rossjohn, J. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.10.004 · Cited by 130
SCART Scavenger Receptors Identify a Novel Subset of Adult γδ T Cells
Kisielow, J., Köpf, M., & Karjalainen, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1710 · Cited by 114
Implication of gamma-delta T cells in the human immune response to cytomegalovirus
Déchanet‐Merville, J. (1999) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)90476-6 · Cited by 102
Self-citationCytomegalovirus-Induced γδ T Cells Associate with Reduced Cancer Risk after Kidney Transplantation
Couzi, L., Vaillant, Y. L., Jamai, A., Pitard, V., Lassalle, R., Martin, K., Garrigue, I., Hawchar, O., Siberchicot, F., Moore, N. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101072 · Cited by 96
Self-citationDotor, J., López-Vázquez, A. B., Lasarte, J. J., Sarobe, P., García‐Granero, M., Riezu‐Boj, J. I., Martínez, A., Feijoó, E., López‐Sagaseta, J., Hermida, J., et al. (2007) · Cytokine · doi:10.1016/j.cyto.2007.06.004 · Cited by 77
Self-citationThe IL-17/IL-23 axis of inflammation in cancer: friend or foe?
Martín‐Orozco, N., & Dong, C. (2009) · PubMed · Cited by 73
Pereira, P., & Boucontet, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3261 · Cited by 52
Self-citationMolecular Analysis of Tumor-Promoting CD8+ T Cells in Two-Stage Cutaneous Chemical Carcinogenesis
Kwong, B. Y., Roberts, S. J., Silberzahn, T., Filler, R. B., Neustadter, J. H., Galan, A., Reddy, S., Lin, W. M., Ellis, P. D., Langford, C. F., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.362 · Cited by 40
Sunaga, S., Maki, K., Komagata, Y., Miyazaki, J., & Ikuta, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4223 · Cited by 38
Self-citationGonçalves‐Sousa, N., Ribot, J. C., deBarros, A., Correia, D. V., Caramalho, Í., & Silva‐Santos, B. (2009) · European Journal of Immunology · doi:10.1002/eji.200939715 · Cited by 36
Does IL-17 suppress tumor growth?
Ngiow, S. F., Smyth, M. J., & Teng, M. W. L. (2010) · Blood · doi:10.1182/blood-2009-11-254607 · Cited by 34
Self-citationDoes IL-17 promote tumor growth?
Muranski, P. J., & Restifo, N. P. (2009) · Blood · doi:10.1182/blood-2009-04-215541 · Cited by 33
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Self-citationImmunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationThe molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
Self-citationImmunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
Metadata
- Authors
- Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apetoh, L., Ghiringhelli, F., Casares, N., Lasarte, J. J., Matsuzaki, G., Ikuta, K., Ryffel, B., Benlagha, K., Tesnière, A., Ibrahim, N., Déchanet-Merville, J., Chaput, N., Smyth, M. J., Kroemer, G., & Zitvogel, L.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-03-07
- Volume
- 208
- Issue
- 3
- Pages
- 491-503
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2995442355
- Cited by
- 337
- References
- 60
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.